Anne Kantardjieff currently serves as Director of Plasmids and Small Molecules Manufacturing at bluebird bio. Her team is responsible for the manufacture of plasmids, small molecules and mRNA to support bluebird bio’s clinical and commercial programs. Prior to that, she was Director of Early Stage Process Development at Alexion Pharmaceuticals, where she had responsibility for Cell Line Development, as well as Upstream and Downstream Process Development of Alexion’s early clinical biologics portfolio. She is the recipient of the 2018 ACS BIOT Van Lanen award, recognizing her service to the Biotechnology Division of the American Chemical Society division, where she has also served as Secretary.